Literature DB >> 16933065

Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder.

Sadiq Al-Hamash1.   

Abstract

Two cases with interrupted inferior vena cava and azygous continuation requiring patent ductus arteriosus (PDA) occlusion per cardiac catheterization are presented. A technique is described enabelmy occlusion of PDA using an Amplatzer ductal occluder despite interruption of inferior vena cava and azygous continuation.

Entities:  

Mesh:

Year:  2006        PMID: 16933065     DOI: 10.1007/s00246-006-1213-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  10 in total

1.  [CONTINUATION AZYGOS OF THE INFERIOR VENA CAVA (APROPOS OF 5 CASES)].

Authors:  C DUPUIS; J P NUYTS; L CHRISTIAENS
Journal:  Arch Mal Coeur Vaiss       Date:  1964-01

2.  Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization.

Authors:  P A Cambier; W C Kirby; D C Wortham; J W Moore
Journal:  Am J Cardiol       Date:  1992-03-15       Impact factor: 2.778

3.  Transcatheter closure of patent ductus arteriosus with buttoned device: first successful clinical application in a child.

Authors:  P S Rao; A D Wilson; E B Sideris; P S Chopra
Journal:  Am Heart J       Date:  1991-06       Impact factor: 4.749

4.  Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results.

Authors:  J Masura; K P Walsh; B Thanopoulous; C Chan; J Bass; Y Goussous; P Gavora; Z M Hijazi
Journal:  J Am Coll Cardiol       Date:  1998-03-15       Impact factor: 24.094

5.  Transluminal closure of patent ductus arteriosus: long-term results of 208 cases treated without thoracotomy.

Authors:  L Wierny; R Plass; W Porstmann
Journal:  Cardiovasc Intervent Radiol       Date:  1986       Impact factor: 2.740

6.  Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion.

Authors:  A Krichenko; L N Benson; P Burrows; C A Möes; P McLaughlin; R M Freedom
Journal:  Am J Cardiol       Date:  1989-04-01       Impact factor: 2.778

7.  Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder.

Authors:  G Fischer; J Stieh; A Uebing; R Grabitz; H H Kramer
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

8.  Transductal guidewire "rail" for balloon valvuloplasty in neonates with isolated critical pulmonary valve stenosis or atresia.

Authors:  L Latson; J Cheatham; S Froemming; J Kugler
Journal:  Am J Cardiol       Date:  1994-04-01       Impact factor: 2.778

Review 9.  Forty-six years of patient ductus arteriosus division at Children's Memorial Hospital of Chicago. Standards for comparison.

Authors:  C Mavroudis; C L Backer; M Gevitz
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA Occluder System.

Authors:  W J Rashkind; C E Mullins; W E Hellenbrand; M A Tait
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

  10 in total
  4 in total

1.  Transcatheter closure of a patent ductus arteriosus in a patient with an anomalous inferior vena cava.

Authors:  S Akhtar; A Akhtar; S M Samad; M Atiq
Journal:  Pediatr Cardiol       Date:  2010-07-06       Impact factor: 1.655

2.  Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder II.

Authors:  Ghee Tiong Koh; Sharifah Ai Mokthar; Amir Hamzah; Jasvinder Kaur
Journal:  Ann Pediatr Cardiol       Date:  2009-07

3.  Percutaneous closure of patent ductus arteriosus in interrupted inferior caval vein through femoral vein approach.

Authors:  Endale Tefera; Ramon Bermudez-Cañete
Journal:  Ann Pediatr Cardiol       Date:  2014-01

4.  Patent Ductus Arteriosus Device Closure in Interrupted Inferior Vena Cava: Challenges Overcome and Lessons Learnt: A Case Series.

Authors:  Palanivel Rajan; Parag Barwad; Pankaj Aggarwal; Manoj Kumar Rohit
Journal:  Heart Views       Date:  2021-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.